# LTS Lohmann Therapie-Systeme AG – FDA Inspection, May 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/lts-lohmann-therapie-systeme-ag/38c1a61e-6d92-4e67-9ac4-31ad61a95b26
Source feed: FDA_Inspections

> FDA inspection 1264907 of LTS Lohmann Therapie-Systeme AG, May 18, 2022. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264907
- Company Name: LTS Lohmann Therapie-Systeme AG
- Inspection Date: 2022-05-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1116639 - 2019-10-31](https://www.keypedia.com/records/fda_inspections/lts-lohmann-therapie-systeme-ag/988777c4-a83f-451d-b1e3-b5bbd8920b69)
- [FDA Inspection 1025276 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/lts-lohmann-therapie-systeme-ag/c1987bd1-1c89-40bd-bd34-a41203873a0c)
- FDA Inspection 865616 - 2013-12-20
- FDA Inspection 735498 - 2011-06-21
- FDA Inspection 605480 - 2009-06-18

Company: https://www.keypedia.com/companies/lts-lohmann-therapie-systeme-ag/1e4dd7e1-b6cb-4ea4-bbfe-fd53318a5151

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c